KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Fulgent Genetics (FLGT) Shares Repurchased (2016 - 2025)

Fulgent Genetics' Shares Repurchased history spans 7 years, with the latest figure at $2.2 million for Q2 2025.

  • For Q2 2025, Shares Repurchased changed N/A year-over-year to $2.2 million; the TTM value through Dec 2025 reached $10.9 million, up 4737.33%, while the annual FY2025 figure was $10.9 million, 4737.33% up from the prior year.
  • Shares Repurchased for Q2 2025 was $2.2 million at Fulgent Genetics, down from $8.7 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $34.7 million in Q3 2022 and bottomed at $225000.0 in Q1 2024.
  • The 5-year median for Shares Repurchased is $8.7 million (2025), against an average of $14.0 million.
  • The largest annual shift saw Shares Repurchased dropped 21.32% in 2023 before it soared 3757.33% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $513000.0 in 2021, then soared by 5564.33% to $29.1 million in 2022, then decreased by 21.32% to $22.9 million in 2023, then crashed by 99.02% to $225000.0 in 2024, then soared by 880.0% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Shares Repurchased are $2.2 million (Q2 2025), $8.7 million (Q1 2025), and $225000.0 (Q1 2024).